DrugDashboards

Fentanyl

Fentanyl · FENTANYL 75 ug/h · Patch, Extended Release · Transdermal · Ingenus Pharmaceuticals, Llc

NDC 50742-0554-05 · 5 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 72 h in 1 PATCH · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is up 17% over the past year, to $15.44 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$15.44per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$11.10per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$6.52per unitGolden State Medical Supply, Inc. · Oct 31, 202542% of what pharmacies pay — a deeper discount than 90% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$15.44per TDPweighted avg manufacturer price $5.3590 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00Mar 2025Sep 2026$15.44
19 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$50.00
Reported to Texas DSHS · 2026 annual filing · Ingenus Pharmaceuticals LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$147,984
1,195 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for fentanyl (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $112.51 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA077449
TE code
AB
Approval date
Oct 20, 2008
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fentanyl (Patch, Extended Release)

LabelerStrengthFirst seenLast seen
Aveva Drug Delivery Systems Inc.FENTANYL 87.5 ug/hJul 15, 2026Sep 2, 2026
Aveva Drug Delivery Systems Inc.FENTANYL 12 ug/hJul 15, 2026Sep 2, 2026
Aveva Drug Delivery Systems Inc.FENTANYL 25 ug/hJul 15, 2026Sep 2, 2026
Aveva Drug Delivery Systems Inc.FENTANYL 37.5 ug/hJul 15, 2026Sep 2, 2026
Aveva Drug Delivery Systems Inc.FENTANYL 50 ug/hJul 15, 2026Sep 2, 2026
Aveva Drug Delivery Systems Inc.FENTANYL 62.5 ug/hJul 15, 2026Sep 2, 2026
Aveva Drug Delivery Systems Inc.FENTANYL 75 ug/hJul 15, 2026Sep 2, 2026
Aveva Drug Delivery Systems Inc.FENTANYL 100 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 87.5 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 100 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 50 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 12 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 75 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 25 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 62.5 ug/hJul 15, 2026Sep 2, 2026
Ingenus Pharmaceuticals, LlcFENTANYL 37.5 ug/hJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fentanyl — NDC 50742-0554-05," retrieved September 3, 2026, https://drugdashboards.com/drug/50742055405.

Free to cite with attribution — see how the data is put together.